Forbion Growth Opportunities Fund I Cooperatief U.A.
Insider CIK 1911047 · FRBNU Director, 10% owner · NAMS 10% owner · ENGN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-30 | 2025-01-02 | 29,846 | $25.54 | $762.3K | 10,656,172 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-27 | 2024-12-30 | 41,472 | $25.95 | $1.08M | 10,686,018 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-26 | 2024-12-30 | 33,438 | $26.01 | $869.7K | 10,727,490 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-24 | 2024-12-26 | 16,164 | $25.66 | $414.8K | 10,760,928 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-23 | 2024-12-26 | 25,132 | $25.49 | $640.6K | 10,777,092 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-20 | 2024-12-26 | 5,629 | $26.13 | $147.1K | 10,802,224 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-20 | 2024-12-26 | 44,143 | $25.53 | $1.13M | 10,807,853 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-19 | 2024-12-20 | 56,506 | $25.45 | $1.44M | 10,851,996 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-18 | 2024-12-20 | 46,210 | $26.55 | $1.23M | 10,908,502 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-18 | 2024-12-20 | 54,518 | $25.72 | $1.40M | 10,954,712 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-17 | 2024-12-18 | 47,736 | $26.45 | $1.26M | 11,009,230 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-17 | 2024-12-18 | 66,648 | $25.60 | $1.71M | 11,056,966 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-16 | 2024-12-18 | 1,096 | $25.00 | $27.4K | 11,123,614 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-13 | 2024-12-16 | 25,751 | $25.01 | $644.0K | 11,124,710 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-12 | 2024-12-16 | 140,048 | $25.25 | $3.54M | 11,176,424 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-12 | 2024-12-16 | 25,963 | $26.18 | $679.7K | 11,150,461 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-11 | 2024-12-12 | 4,894 | $27.11 | $132.7K | 11,316,472 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-11 | 2024-12-12 | 18,583 | $26.41 | $490.8K | 11,321,366 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-11 | 2024-12-12 | 130,561 | $25.26 | $3.30M | 11,339,949 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-10 | 2024-12-12 | 259,739 | $25.22 | $6.55M | 11,519,021 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-12-10 | 2024-12-12 | 48,511 | $26.15 | $1.27M | 11,470,510 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-11-18 | 2024-11-19 | 33,273 | $25.08 | $834.5K | 11,778,760 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-11-15 | 2024-11-19 | 8,530 | $25.02 | $213.4K | 11,812,033 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-11-14 | 2024-11-15 | 9,832 | $25.01 | $245.9K | 11,820,563 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | S Sale | 2024-11-13 | 2024-11-15 | 1,066 | $25.00 | $26.6K | 11,830,395 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-30 | 2024-11-01 | 561,797 | $8.90 | $5.00M | 3,032,430 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-08 | 2024-10-18 | 800 | $6.60 | $5.3K | 2,470,633 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-07 | 2024-10-18 | 11,844 | $6.55 | $77.6K | 2,469,833 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-04 | 2024-10-18 | 5,997 | $6.54 | $39.2K | 2,457,989 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-03 | 2024-10-18 | 5,769 | $6.48 | $37.4K | 2,451,992 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-02 | 2024-10-18 | 10,153 | $6.37 | $64.7K | 2,446,223 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-10-01 | 2024-10-18 | 35,279 | $6.44 | $227.2K | 2,436,070 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-09-30 | 2024-10-18 | 341,332 | $6.34 | $2.16M | 2,400,791 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-09-27 | 2024-10-18 | 3,243 | $6.38 | $20.7K | 2,059,459 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2024-09-27 | 2024-10-18 | 38,396 | $5.94 | $228.1K | 2,056,216 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2023-12-29 | 2024-10-18 | 9,620 | $9.09 | $87.4K | 2,017,820 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2023-12-29 | 2024-10-18 | 400 | $8.30 | $3.3K | 2,008,200 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2023-12-28 | 2024-10-18 | 5,050 | $7.69 | $38.8K | 2,007,800 | SEC↗ |
| ENGN enGene Holdings Inc. | P Buy | 2023-12-27 | 2024-10-18 | 2,750 | $7.17 | $19.7K | 2,002,750 | SEC↗ |
| ENGN enGene Holdings Inc. | J Other deriv | 2023-10-31 | 2023-11-02 | 950,153 | — | $0 | 1,736,406 | SEC↗ |
| ENGN enGene Holdings Inc. | J Other deriv | 2023-10-31 | 2023-11-02 | 54,634 | — | $0 | 786,253 | SEC↗ |
| ENGN enGene Holdings Inc. | J Other | 2023-10-31 | 2023-11-02 | 130,085 | — | $0 | 1,503,581 | SEC↗ |
| ENGN enGene Holdings Inc. | J Other | 2023-10-31 | 2023-11-02 | 2,262,351 | — | $0 | 3,765,932 | SEC↗ |
| FRBNU Forbion European Acquisiti | D To issuer deriv | 2023-10-30 | 2023-10-31 | 666,666 | — | $0 | 0 | SEC↗ |
| FRBNU Forbion European Acquisiti | D To issuer deriv | 2023-10-30 | 2023-10-31 | 731,619 | — | $0 | 0 | SEC↗ |
| FRBNU Forbion European Acquisiti | D To issuer | 2023-10-30 | 2023-10-31 | 1,373,496 | — | $0 | 0 | SEC↗ |
| FRBNU Forbion European Acquisiti | D To issuer | 2023-10-30 | 2023-10-31 | 2,000,000 | — | $0 | 0 | SEC↗ |
| FRBNU Forbion European Acquisiti | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000,000 | $1.50 | $1.50M | 731,619 | SEC↗ |
| FRBNU Forbion European Acquisiti | C Conversion deriv | 2023-10-27 | 2023-10-31 | 1,373,496 | — | $0 | 0 | SEC↗ |
| FRBNU Forbion European Acquisiti | C Conversion | 2023-10-27 | 2023-10-31 | 1,373,496 | — | $0 | 1,373,496 | SEC↗ |